Industry Adoption Panel - Panelist
Rob Goodwin, MS, MBA, Vice President, Head of Operations Center of Excellence, Pfizer
Rob Goodwin is Vice President and Head of the Pfizer Global Product Development Operations Center of Excellence, a discipline dedicated to service development activities across Pfizer. In this role he is responsible for SOPs, Training, Contracting and Information Management across the development continuum for Clinical, Safety and Regulatory. In addition, he holds the executive relationships with the preferred Contract Research Organizations (CROs) as well as the analytics generation for reporting on performance and cycle times across clinical studies. In support of advancing the portfolio and innovation, Rob has responsibility for the Clinical Innovation group.
From 2010 to 2015, Rob served for as the Vice President of Safety Evaluation and Reporting in Worldwide Safety and Regulatory where he was responsible for the local affiliates, Case Processing, Medical Review, Aggregate Reporting as well as Medical Authoring. Prior to that, he was Vice President of Operational Excellence and Business Innovation for Safety, Regulatory and Medical responsible for Pharmacovigilance Agreements, Contracts and Outsourcing, Project Management, Continuous Improvement and Metrics Reporting and Safety and Regulatory Innovation. From 2005 to 2010, Rob was the Vice President and World Wide Head of Global Clinical Data Services in Development Operations.
He has over 27 years of industry experience in statistics, SAS programming, data management, electronic data capture, safety and strategic project management. Rob has lead the EDC (Electronic Data Capture) initiative at Pfizer and was recognized in 2002 with a Pfizer Presidents achievement and later in 2005 for his work for Process Harmonization and Optimization across Development Operations and Clinical. In February 2004, Rob was recognized in CIO Magazine as the Healthcare Industry winner for the Pfizer implementation of EDC. Rob is an executive Black Belt and has been a past member of PhRMA and a board member for CDISC (Clinical Data Interchange Standards Consortium).
Rob holds a B.S. in Psychology from Eastern Connecticut State University, a M.S. in Research, Measurement and Evaluation from Southern Connecticut State University and an M.B.A. in Pharmaceutical and Chemical Studies.